Cyclophosphamide with or without fluorouracil followed by subcutaneous or intravenous interleukin-2 use in solid tumors: A feasibility off-label experience

Giovanni Lo Re, Francesco Lo Re, Paolo Doretto, Alessandro Del Conte, Maria Amadio, Cinzia Cozzi, Maria Maddalena Casarotto, Daniele Maruzzi, Wally Marus, Paolo Ubiali, Paolo Sandri

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Cyclophosphamide with or without fluorouracil followed by subcutaneous or intravenous interleukin-2 use in solid tumors: A feasibility off-label experience'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds